research COVID-19-Associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study
Many severe COVID-19 patients experienced temporary hair loss, but most regrew hair within six months.
Search
for
Sort by
Research
270-300 / 1000+ results 
research Red LED Light Therapy for Telogen Effluvium in Long COVID Patients With and Without Androgenetic Alopecia
Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.
research Is Thyroid Dysfunction a Common Cause of Telogen Effluvium? A Retrospective Study
Hypothyroidism is often linked to the hair loss condition telogen effluvium.
research Culprits of Medication-Induced Telogen Effluvium, Part 2
Some blood thinners and blood pressure medicines can cause hair loss, which usually starts 1 to 6 months after beginning the medication.
research Telogen Effluvium Associated with Weight Loss: A Single Center Retrospective Study
Weight loss can cause temporary hair loss, especially in women and older adults.
research The Relationship Between Telogen Effluvium and Post-COVID-19 Infection at Klinik Sukma, January 2023-February 2023
Post-COVID-19 patients are at risk for hair loss.
research Culprits of Medication-Induced Telogen Effluvium, Part 1
Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.
research Telogen Effluvium: A 360 Degree Review
Telogen effluvium is a common, often temporary hair loss caused by stress and other factors, and it's hard to pinpoint and treat.
research Efficacy of Adipocyte-Derived Stem Cells-Conditioned Media in Telogen Effluvium
A new treatment using stem cell-conditioned media significantly improved hair growth in people with temporary hair loss.
research Telogen Effluvium: A Post-COVID-19 Sequela
COVID-19 may cause a common type of hair loss called telogen effluvium.
research Oral Vitamin D Treatment in Patients with Telogen Effluvium: Clinical and Dermoscopic Evaluation
Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.
research Review Article on Telogen Effluvium
COVID-19 survivors working in healthcare may experience temporary hair loss.
research Telogen Effluvium and COVID-19: A Cross-Sectional Study
COVID-19 infection is highly related to increased hair loss, especially in women.
research Micronutrient Deficiencies and Digital Phototrichogram Analysis in Telogen Effluvium: A Retrospective Study in a Tertiary Medical Center
Low hemoglobin levels are significantly correlated with hair loss in women with Telogen Effluvium.
research Impact of Stem Cell-Based Therapy and Platelet-Rich Plasma in Hair Loss and Telogen Effluvium Related to COVID-19
Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.
research Associations of Telogen Effluvium With Coronavirus Disease 2019 and Research Progress in Its Diagnosis and Treatment
COVID-19 may cause common hair loss due to stress, immune response, medications, and other health issues.
research Serum Plasma Thiol Evaluation in Chronic Telogen Effluvium Patients
People with chronic hair shedding have lower antioxidant levels in their blood compared to healthy individuals.
research Telogen Effluvium
Telogen effluvium is a form of hair loss caused by various factors and requires identifying the cause for proper treatment.
research Efficacy and Tolerability of an Oral Supplement Containing Amino Acids, Iron, Selenium, and Marine Hydrolyzed Collagen in Subjects With Hair Loss: A Prospective, Randomized, 3-Month, Controlled, Assessor-Blinded Study
The supplement with amino acids, iron, selenium, and marine hydrolyzed collagen improved hair growth more than drug treatment alone, with most people tolerating it well.
research Clinical Study on the Efficacy and Tolerability of an Oral Supplement Based on Arginine, L-Cystine, Zinc and B6 Vitamin (Cystiphane) in Patients With Telogen Effluvium
The oral supplement improved hair loss in patients with telogen effluvium.
research Correlation Between Serum Ferritin and Hemoglobin Level in Females With Hair Fall in Chronic Telogen Effluvium
Low iron levels are linked to more hair loss in women with chronic hair shedding.
research Evaluation of the Relationship Between Favipiravir Use and Telogen Effluvium in COVID-19 Patients
Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.
research Shedding Low Yield Testing for Telogen Effluvium: A Cross-Sectional Study of Laboratory Results from Newly Diagnosed Patients
Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.
research Serum Vitamin D3 Levels in Patients with Telogen Effluvium in Duhok Governorate
People with telogen effluvium often have much lower vitamin D levels than healthy individuals.
research Scalp Capillarectasia as a Trichoscopic Sign of COVID-19-Associated Telogen Effluvium
Dilated scalp capillaries might be a sign of hair loss related to COVID-19.
research Dengue-Associated Telogen Effluvium Causing Body Dysmorphic Disorder
Dengue fever can cause hair loss that may lead to serious psychological issues like Body Dysmorphic Disorder in young women.
research Telogen Effluvium, Diagnosis and Management: A Narrative Review
Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.
research Serum Zinc Level in Telogen Effluvium Patients
People with Telogen Effluvium have similar zinc levels in their blood as healthy individuals.
research Telogen Effluvium
Telogen effluvium is a hair loss condition that can be treated with medications like minoxidil.
research Prevalence Of Telogen Effluvium In Egyptian Women With Post-Covid 19 Viral Infection
Many Egyptian women who were hospitalized for COVID-19 experienced significant hair loss afterwards.